Page 25 - ARUBA TODAY
P. 25

BUSINESS                 Friday 29 September 2017
                                                                                                                           A25

            Gains for drugmakers help US stocks reach new records



                                                                                                   The Standard & Poor’s 500  Its  stock  gained  $4.21,  or
                                                                                                   index rose 3.02 points, or 0.1  5  percent,  to  $88.96  and
                                                                                                   percent,  to  a  record  high  Amgen  rose  58  cents  to
                                                                                                   of 2,510.06. The Dow Jones  $185.46.  Abbott  Laborato-
                                                                                                   industrial  average  gained  ries jumped after the Food
                                                                                                   40.49 points, or 0.2 percent,  and  Drug  Administration
                                                                                                   to  22,381.20.  The  Nasdaq  approved its FreeStyle Libre
                                                                                                   composite  inched  up  0.19  Flash  glucose  monitoring
                                                                                                   points to 6,453.45. The Rus-  system for adults with Type 1
                                                                                                   sell  2000  index  of  smaller-  diabetes. The product uses
                                                                                                   company stocks continued  a sensor inserted below the
                                                                                                   to  set  new  highs  as  it  ad-  skin to measure blood glu-
                                                                                                   vanced  3.97  points,  or  0.3  cose.  Analysts  say  Abbott
                                                                                                   percent, to 1,488.79. Drug-  could  have  a  competitive
                                                                                                   maker  AbbVie  climbed  edge because the FDA did
                                                                                                   after  it  resolved  a  patent  not advise patients to take
                                                                                                   dispute  over  Amgen’s  ver-  samples  of  their  blood  to
                                                                                                   sion  of  AbbVie’s  drug  Hu-  confirm  the  system’s  read-
                                                                                                   mira, which is the source of  ings.
                                                                                                   most of its revenue. Amgen  Abbott rose $1.9, or 2.9 per-
                                                                                                   agreed not to begin selling  cent,  to  $53.64.  DexCom,
            This Friday, Jan. 15, 2016 photo shows a sign for a Wall Street subway station in New York. U.S.   its version of the anti-inflam-  which  gets  all  its  revenue
            stocks finished slightly higher Thursday, led by technology companies and drugmakers.  matory medicine in Europe  from  selling  its  own  blood
                                                                         (AP Photo/Mark Lennihan)  until October 2018, and the  glucose monitoring system,
            By MARLEY JAY                well  as  U.S.  stocks  in  2017,  that are linked to U.S. eco-  U.S. version won’t go on the  plunged  $22.03,  or  32.7
            AP Markets Writer            and  with  the  European  nomic  growth,  like  banks  market until Jan. 31, 2023.     percent, to $45.44 in heavy
            NEW  YORK  (AP)  —  U.S.     Central Bank getting ready  and  industrial  and  con-    The    settlement   would  trading.  Spice  maker  Mc-
            stocks finished slightly high-  to start raising interest rates,  sumer-focused   compa-  mean  billions  of  dollars  in  Cormick  raised  its  profit
            er  Thursday,  led  by  tech-  banks in Europe should start  nies, should continue to do  additional sales for AbbVie,  and  revenue  estimates  af-
            nology  companies  and       making more money.           well.  Those  stocks  mostly  which  reported  $16  bil-  ter  it  beat  expectations  in
            drugmakers.  After  a  big   But  Samana  thinks  stocks  climbed on Thursday.         lion in Humira sales in 2016.  the fiscal third quarter. q
            move the day before, that
            was enough to take stocks    Kellogg chooses vitamin executive as next CEO
            back to record highs.
            After  a  slow  start,  stocks   NEW YORK (AP) — Kellogg’s  C vitamins.                every year since 2013.       smaller,  local  brands  and
            gradually  moved  upward     CEO  is  retiring  and  will  be  Cahillane  will  start  as  CEO  Bryant  said  Cahillane’s  ex-  are  worried  about  the  in-
            in  afternoon  trading  as   succeeded  by  an  execu-    next week and will join the  perience at Nature’s Boun-   gredients  they  eat.  Battle
            companies  in  technology,   tive  from  a  vitamin  and  company’s  board.  Bryant,  ty  would  help  Kellogg  ad-  Creek,   Michigan-based
            basic materials, real estate   protein  bar  company,  as  51,  will  remain  executive  just to consumers’ demand  Kellogg has said it will add
            and  finance  contributed    packaged food makers try  chairman of the board un-       for healthier food, but that  probiotics  to  its  Special  K
            modest  gains.  Drugmak-     to keep customers who are  til  March,  when  Cahillane  it  wouldn’t  apply  to  all  of  cereal later this year to try
            er  AbbVie  jumped  after    looking  for  healthier  prod-  will take over that role. Ca-  Kellogg’s products.     to boost sales.
            it  reached  a  deal  with  a   ucts.                     hillane, 52, has also worked  “I  think  in  our  cereal  busi-  Kellogg  and  competitors
            competitor that would de-    The maker of Frosted Flakes,  at  soda  company  Coca-    ness,  health  and  wellness  like  General  Mills  and  Post
            lay competition for its anti-  Pop-Tarts and Eggo waffles  Cola  Co.  and  beer  maker  is  important,”  Bryant  said.  have  also  been  cutting
            inflammatory     treatment   said  Chief  Executive  John  AB InBev.                   “The  snacks  business  is  costs  and  changing  strat-
            Humira,  the  biggest-selling   Bryant will be replaced by  Kellogg  has  struggled  to  more  about  indulgence  egies  as  consumer  trends
            drug in the world. Industrial   Steven  Cahillane,  an  ex-  make its cereals and snacks  and taste.”               shift  away  from  processed
            firms  took  small  losses  as   ecutive  from  The  Nature’s  more  appealing  to  Ameri-  Packaged  food  conglom-  foods. General Mills, which
            big names like Boeing and    Bounty  Co.  That  company  cans  who  are  increasingly  erates have been trying to  makes  Cheerios  and  Trix
            General Electric declined.   makes  Balance  bars,  Sol-  seeking to avoid processed  appeal  more  to  consum-     cereals,  also  replaced  its
            September  is  historically   gar supplements and Ester-  food. Its revenue has fallen  ers who favor fresher foods,  CEO back in June. q
            the weakest month of the
            year  for  stocks,  but  the
            Standard  &  Poor’s  500     Roku’s stock soars after IPO raises $219M
            has  risen  1.6  percent  this
            month.  The  third  quarter   By TALI ARBEL               $23.50. The Los Gatos, Cali-  users, whether on its home  able  and  has  amassed
            ends Friday, and the index    AP Technology Writer        fornia,  company  is  known   screen or inside video apps.  $244 million in losses since it
            has  climbed  12  percent     NEW  YORK  (AP)  —  Shares  for its boxes and sticks that   The  company  is  unprofit-  was founded in 2002.q
            this year. That has some in-  of Roku, an early player in  let users watch Netflix, Hulu
            vestors  wondering  if  other   streaming-video  gadgets,  and  the  growing  universe
            markets  are  poised  to  do   soared Thursday after its ini-  of streaming-video options
            better  than  U.S.  stocks  in   tial public offering of stock  on their TVs. It has the big-
            the months to come.           raised $219 million.        gest  share  of  the  stream-
            “The  U.S.  economic  cycle   The  shares  priced  at  $14  ing-gadget  market,  but
            is  so  much  further  along   each, the top of the com-  has  deep-pocketed  com-
            than the Europe economic      pany’s  expected  range,  petitors in Amazon, Google
            cycle,”  said  Sameer  Sa-    suggesting strong demand  and Apple. Most of Roku’s
            mana,  global  quantita-      from investors and valuing  revenue comes from sales
            tive  strategist  for  the  Wells   the company at $1.3 billion.  of its streaming players, but
            Fargo  Investment  Institute.   The shares rocketed almost  it’s seeking to capitalize on
            He  added  that  European     68  percent  Thursday,  clos-  its “platform” by building its
            stocks  haven’t  done  as     ing the day at their peak of  business of showing ads to
   20   21   22   23   24   25   26   27   28   29   30